Most, if not all, of the studies that report cognitive impairments in patients who have been treated with cancer chemotherapy also report deficits involving the visual system (e.g., visual-spatial function or visual memory). The visual system seems like a likely susceptible target of cytotoxic drugs. Therefore, some portion of the vision-related cognitive deficits of chemo fog/chemo brain might result from a direct action of the drugs or from site/site interaction between effects on the visual system and other critical brain regions. This chapter is a succint summary of a more expanded review.1 © 2010 Landes Bioscience and Springer Science+Business Media.
CITATION STYLE
Raffa, R. B. (2010). Chemotherapy-related visual system toxicity. Advances in Experimental Medicine and Biology. https://doi.org/10.1007/978-1-4419-6306-2_14
Mendeley helps you to discover research relevant for your work.